CD19 and neoplasm: Rotolo et al. optimized CAR-NKT cell production and showed an anti-tumor effect of CAR19-iNKT over CAR-T cells in terms of both tumor-free and overall survival in an in vivo mouse model of CD1d+CD19+ B lineage cancer.